These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37455810)

  • 1. Professional and governmental policy on community pharmacy: A 10-year policy review and comparative analysis (2008-2017).
    Paloumpi E; Ozieranski P; Watson MC; Jones MD
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100298. PubMed ID: 37455810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Powers, engagements and resultant influences over the design and implementation of medicine pricing policies in Ghana.
    Koduah A; Baatiema L; Kretchy IA; Agyepong IA; Danso-Appiah A; de Chavez AC; Ensor T; Mirzoev T
    BMJ Glob Health; 2022 May; 7(5):. PubMed ID: 35589156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trauma-informed care in the UK: where are we? A qualitative study of health policies and professional perspectives.
    Emsley E; Smith J; Martin D; Lewis NV
    BMC Health Serv Res; 2022 Sep; 22(1):1164. PubMed ID: 36104750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
    Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
    Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do organisational configuration and context influence the quantity and quality of NHS services provided by English community pharmacies? A qualitative investigation.
    Jacobs S; Fegan T; Bradley F; Halsall D; Hann M; Schafheutle EI
    PLoS One; 2018; 13(9):e0204304. PubMed ID: 30235289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
    Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacy minor ailment services: Pharmacy stakeholder perspectives on the factors affecting sustainability.
    Nazar H; Nazar Z
    Res Social Adm Pharm; 2019 Mar; 15(3):292-302. PubMed ID: 29778343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence?
    Mossialos E; Naci H; Courtin E
    Health Policy; 2013 Jul; 111(2):135-48. PubMed ID: 23706523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing status in health care: community and hospital pharmacists' perceptions of pharmacy practice.
    Altman IL; Mandy PJ; Gard PR
    Int J Pharm Pract; 2019 Jun; 27(3):249-255. PubMed ID: 30592351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple policy approaches in improving community pharmacy practice: the case in Indonesia.
    Hermansyah A; Sainsbury E; Krass I
    BMC Health Serv Res; 2018 Jun; 18(1):449. PubMed ID: 29898723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating evidence into policy and sustainable disability services delivery in western New South Wales, Australia: the 'wobbly hub and double spokes' project.
    Veitch C; Lincoln M; Bundy A; Gallego G; Dew A; Bulkeley K; Brentnall J; Griffiths S
    BMC Health Serv Res; 2012 Mar; 12():70. PubMed ID: 22436650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.
    Cheng JS; Lee MJ; Massicotte E; Ashman B; Gruenberg M; Pilcher LE; Skelly AC
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S144-63. PubMed ID: 21952186
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.